JJET致力於開發、生產和銷售的產品領域的電生理學;產品主要包括三維心髒映射係統,多道生理記錄儀,心髒電生理刺激,心髒射頻消融設備,冷鹽水灌注泵、心髒電生理導管的映射,心髒射頻消融導管,神經射頻治療儀器。公司成立於1991年,總部設在成都,中國。

Rubicor醫療是一個私人醫療設備公司位於紅木市,加利福尼亞。我們的專有活檢技術(鼓掌乳房活檢設備)是一個戲劇性的改善當前微創活檢技術。14號的Ovation係統由活檢設備切割的能力,捕捉和提取完整的2.5厘米直徑的組織樣本。熱烈歡迎兼容超聲波或立體定向形象指導。Rubicor由詹姆斯檢查者和博士已經與私人資助的個人投資者組成的財團。詹姆斯·w .檢查者,醫學博士首席執行官和董事會主席,是一個委員會認證的介入心髒病學家。他是斯坦福大學醫院臨床醫學副教授,他在那裏目前活躍的員工作為社區學院。檢查者博士畢業於威斯康辛醫學院,他完成了一個居住在內科和心髒病的獎學金。檢查者博士完成了介入性心髒病學和約翰·辛普森博士,醫學博士獎學金。在紅杉醫院,加州雷德伍德城。 Dr. Vetter is a member of the Alpha Omega Alpha Honor Society and the American College of Cardiologists. He has published six articles and several book chapters as well as over 35 abstracts. Dr. Vetter has held positions as a member of the Physician Advisory Council and/or board member with a number of medical device companies including Guidant, Lumend, Fox Hollow and CardioVasc. He is also a board member of Magellan Systems International, Inc. Dr. Vetter has extensive experience in working with new medical device concepts and designs, working with R&D engineers to develop working prototypes and clinically testing and refining those products. He was co-founder of Perclose and was involved with that company from inception to initial public offering and eventual sale to Abbott Labs. He is a "hands on" clinician with access to resources and expertise needed to build a successful medical device and company. Dr. Vetter has had a number of patents issued in his name as co-inventor. Ary Chernomorsky, V.P. of R&D since 2000 has over 23 years experience in the medical device industry. Prior to joining Rubicor, Mr. Chernomorsky was employed by the Vascular Therapies division of US Surgical Company (acquired by Tyco International), where he served as a Director of R&D. Mr. Chernomorsky has been involved with various startup companies in the R&D Director and Manager capacities including: PAS Inc. (acquired by USS), Advanced Surgical, Inc. (acquired by Imagyn), Micro Therapeutics, Bausch and Lomb, Mentor Corporation and Dart Industries Inc. Ary holds an M.S. in Polymer Engineering from LIT and an M.S. in Biomedical Engineering from Rutgers University. Tony Difede, CPA, V.P. Finance holds a BSBA degree in Accounting from the University of Florida and a M.S. in Taxation from Pace University. He has held management positions in tax and accounting with Ernst & Young, KPMG and my CFO, Inc. His clients have included closely held start-up companies as well as large multinational public corporations. He is licensed in California and New Jersey. He has extensive experience in accounting for stock options and issues regarding closely held companies and their high net worth owners and investors. COMPANY INFO MANAGEMENT page 1 2006 Company Overview (Continued) Breast care. Completely redefined. James W. Vetter, M.D., Founder and Chairman of the Board, is a board certified interventional cardiologist. He is an Associate Professor of Clinical Medicine at Stanford University Hospital, where he is currently on Active Staff status as community faculty. Dr. Vetter is a graduate of the Medical College of Wisconsin where he completed a residency in internal medicine and a fellowship in cardiology. Dr. Vetter completed an interventional cardiology fellowship with Dr. John Simpson M.D./PhD., at Sequoia Hospital, Redwood City, Cal

哥倫比亞大學生物係統公司是一家從事分子Nano-diagnostics使用分子印跡聚合物(MIPs)等病原體的快速檢測耐甲氧西林金黃色葡萄球菌(MRSA),炭疽,艾滋病毒,和錐蟲病(昏睡病)。公司采用MIPs結合蛋白質,在綁定,從而改變顏色信號的存在細菌、病毒或寄生蟲。

小噬細胞的使命是成為一個在全球範圍內快速的細菌診斷的先驅,在細菌鑒定和藥敏/電阻測試,通過其bacteriophage-based放大免疫測定診斷平台。

Flex生物醫學發展技術能幫助我們找到診斷和治療骨科疾病。Flex生物醫學的主要產品是合成聚合物,Flex聚合物,用於治療骨關節炎。

Litholink提供代謝評估腎髒結石患者。